The Future of Pharmaceutical Manufacturing: Flexibility and Sustainability through Small-Footprint, Modular Equipment Trains
Posted on June 22,2017
Introduction Following a decade (or more)1 of concerted effort by industry, regulator, and academic groups, recent technology investments are now beginning to shape how medicines are being developed and manufactured for the global marketplace. While significant focus has highlighted the emergence of...
To read the full article and other articles in this issue, please register for an account or log in.
Related Topics and Keywords
an immediate-release solid oral dosage, commercial supply flexibility, continuous manufacturing processes, Daniel O. Blackwood, distribution, extended supply chain networks, FDA’s Breakthrough Therapy designation, Flexability, high-value personalized medicines, Jeffrey Moriarty, manufacturing, manufacturing localization, Modular Equipment Trains, new regulatory pathways, Pfizer, pharmaceutical development, product development speed, Small Footprint, supply chain networks, sustaianability, targeted biology